Prostacyclin Receptor Agonist [EPC] - N0000192339

Pharmacologic Code	N0000192339
Pharmacologic Name	Prostacyclin Receptor Agonist
Pharmacologic Uses	prostacyclin receptor agonist
Pharmacologic Concept	Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description	An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions: A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication. A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

The table contains 9 products whose active ingredient are classified under the same pharmacologic class Prostacyclin Receptor Agonist [EPC].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	66215-602	Uptravi	Non-Proprietary Name: Selexipag	Tablet, Coated	Oral	Actelion Pharmaceuticals Us, Inc.	ACTIVE
	66215-604	Uptravi	Non-Proprietary Name: Selexipag	Tablet, Coated	Oral	Actelion Pharmaceuticals Us, Inc.	ACTIVE
	66215-606	Uptravi	Non-Proprietary Name: Selexipag	Tablet, Coated	Oral	Actelion Pharmaceuticals Us, Inc.	ACTIVE
	66215-608	Uptravi	Non-Proprietary Name: Selexipag	Tablet, Coated	Oral	Actelion Pharmaceuticals Us, Inc.	ACTIVE
	66215-610	Uptravi	Non-Proprietary Name: Selexipag	Tablet, Coated	Oral	Actelion Pharmaceuticals Us, Inc.	ACTIVE
	66215-612	Uptravi	Non-Proprietary Name: Selexipag	Tablet, Coated	Oral	Actelion Pharmaceuticals Us, Inc.	ACTIVE
	66215-614	Uptravi	Non-Proprietary Name: Selexipag	Tablet, Coated	Oral	Actelion Pharmaceuticals Us, Inc.	ACTIVE
	66215-616	Uptravi	Non-Proprietary Name: Selexipag	Tablet, Coated	Oral	Actelion Pharmaceuticals Us, Inc.	ACTIVE
	66215-718	Uptravi	Non-Proprietary Name: Selexipag	Injection, Powder, For Solution	Intravenous	Actelion Pharmaceuticals Us, Inc.	ACTIVE